Challenges to Lifestyle Medicine for Type 2 Diabetes in Iran: A Synoptic Review

被引:1
|
作者
Firouzabadi, Mohammad Dehghani
Sheikhy, Ali
Poopak, Amirhossein
Esteghamati, Alireza [1 ]
Mechanick, Jeffrey I.
Firouzabadi, Fatemeh Dehghani
机构
[1] Univ Tehran Med Sci, Vali Asr Hosp, Endocrinol & Metab Res Ctr EMRC, Tehran 13145784, Iran
关键词
behavioral medicine; belief systems; implementation; Iran; lifestyle management; type; 2; diabetes; SELF-MANAGEMENT EDUCATION; MEDICATION ADHERENCE; GLYCEMIC CONTROL; RISK-FACTORS; CHRONIC DISEASES; HEALTH; CARE; PREVALENCE; BARRIERS; PROGRAM;
D O I
10.1177/15598276231167787
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Type 2 diabetes (T2D) is a major public health issue in Iran. The principal context for T2D management is the prevention of cardiovascular disease development and progression. These preventive strategies can be enhanced with routine implementation of comprehensive lifestyle modification, guideline-directed medical therapies, and creation of infrastructure that considers social determinants of health, ethnocultural variables, and financial challenges. In this synoptic review, scientific evidence sourced from Iran is analyzed to identify tactics to optimize the lifestyle medicine component of T2D care in Iran. Important evidence-based factors gleaned from the literature were curated into 9 categories: self-care, dietary adherence, mental health, self-comparison, transcultural adaptation, family support and community engagement, physical activity, the global pandemic, and service delivery. These categories were then assigned to 1 of 4 a priori aspects challenging diabetes care in Iran: behavioral factors, belief system, drivers, and implementation. By codifying discussion points and individual tactics, the improvement and optimization of T2D care in Iran can be facilitated. This reductionist model of approaching lifestyle medicine and complex chronic disease such as T2D can be applied to other ethnocultural populations.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Personalized medicine of type 2 diabetes
    Weiping Jia
    Frontiers of Medicine, 2013, 7 : 1 - 3
  • [42] Personalized medicine of type 2 diabetes
    Jia, Weiping
    FRONTIERS OF MEDICINE, 2013, 7 (01) : 1 - 3
  • [43] Precision Medicine for Type 2 Diabetes
    Villagran, Marcelo
    Martorell, Miquel
    Diaz, Fredy
    Petermann-Rocha, Fanny
    Celis-Morales, Carlos
    REVISTA MEDICA DE CHILE, 2022, 150 (02) : 273 - 275
  • [44] Precision medicine in type 2 diabetes
    Prasad, R. B.
    Groop, L.
    JOURNAL OF INTERNAL MEDICINE, 2019, 285 (01) : 40 - 48
  • [45] Personalized medicine in Type 2 Diabetes
    Liao, Wen-Ling
    Tsai, Fuu-Jen
    BIOMEDICINE-TAIWAN, 2014, 4 (02): : 1 - 8
  • [46] Diabetes remission after a lifestyle-medicine intervention on type 2 diabetes in lean and obese Chinese subjects: a prospective study
    Zou, Wenying
    Luo, Kunyuan
    Hu, Zhiyong
    Zhang, Xiongchou
    Feng, Cuiping
    Ye, Dingkang
    Liu, Shenghao
    Zhang, Qiwei
    Tan, Rongshao
    Fu, Chengbin
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (04) : 1462 - 1472
  • [47] Current challenges in type 2 diabetes
    Garber, Alan J.
    DIABETES OBESITY & METABOLISM, 2012, 14 : 1 - 3
  • [48] Lifestyle Approach for Type 2 Diabetes and Metabolic Syndrome
    Esposito, Katherine
    Ciotola, Miryam
    Maiorino, Maria Ida
    Giugliano, Dario
    CURRENT ATHEROSCLEROSIS REPORTS, 2008, 10 (06) : 523 - 528
  • [49] Lifestyle is of great importance in Type-2 Diabetes
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2018, 7 (05) : 348 - 350
  • [50] Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes
    Jonathan McGavock
    Allison Dart
    Brandy Wicklow
    Current Diabetes Reports, 2015, 15